Medistim — Remuneration Information 2021

Jan 27, 2021

Transfer of shares to CEO

Transfer of shares to CEO

Medistim ASA has transferred 12,500 shares to Medistim CEO Kari Krogstad. It is part of her agreement with the Board of Medistim that she receives 12,500 shares. The agreement has been previously described in the Company's Annual Report. Medistims last traded share price in 2020 was 250.00 so the shares are transferred at this cost. Medistim ASA has 136,500 own shares and after the transfer to Kari Krogstad the company has 124,000 own shares shares. Kari Krogstad has after the latest transfer 91,802 shares in Medistim ASA.